Investigating the Prenatal Testing Market

The Daily

04-01-2022 • 25 mins

About a decade ago, companies began offering pregnant women tests that promised to detect rare genetic disorders in their fetuses.

The tests initially looked for Down syndrome and worked well, but later tests for rarer conditions did not. An investigation has found that the grave predictions made by those newer tests are usually incorrect.

We look at why the tests are so wrong and what can be done about it.

Guest: Sarah Kliff, an investigative reporter for The New York Times.

Sign up here to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter.

Background reading:

For more information on today’s episode, visit

nytimes.com/thedaily

. Transcripts of each episode will be made available by the next workday.

You Might Like

The Morning Brief
The Morning Brief
The Economic Times
ANI Podcast with Smita Prakash
ANI Podcast with Smita Prakash
Asian News International (ANI)
ThePrint
ThePrint
ThePrint
3 Things
3 Things
Express Audio
FT News Briefing
FT News Briefing
Financial Times
Top of the Morning
Top of the Morning
Mint - HT Smartcast
Economist Podcasts
Economist Podcasts
The Economist
HT Daily News Wrap
HT Daily News Wrap
Hindustan Times - HT Smartcast
Daybreak
Daybreak
The Ken
The Journal.
The Journal.
The Wall Street Journal & Gimlet
The Daily
The Daily
The New York Times
Serial
Serial
Serial Productions & The New York Times
WSJ Tech News Briefing
WSJ Tech News Briefing
The Wall Street Journal
WSJ What’s News
WSJ What’s News
The Wall Street Journal
The Signal Daily
The Signal Daily
The Core Team
Global News Podcast
Global News Podcast
BBC World Service